Naftifine

CHEMBL626 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
287.4 g/mol
LogP
5.1
Phase
4

This antifungal cream or gel is applied to the skin to treat fungal infections such as athlete's foot, jock itch, and ringworm. It works by stopping the growth of the fungi responsible for these infections, typically clearing symptoms within two to four weeks of daily application.

Masse moléculaire

287,4000 g/mol

LogP

5,10

TPSA

3,20 Ų

Règle des 5 de Lipinski

Conforme

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN(C/C=C/c1ccccc1)Cc1cccc2ccccc12

InChI

InChI=1S/C21H21N/c1-22(16-8-11-18-9-3-2-4-10-18)17-20-14-7-13-19-12-5-6-15-21(19)20/h2-15H,16-17H2,1H3/b11-8+

Molecular Formula

C21H21N

HBD / HBA

- / 1

Liaisons Rotatives

5

Atomes Lourds

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

This antifungal cream or gel is applied to the skin to treat fungal infections such as athlete's foot, jock itch, and ringworm. It works by stopping the growth of the fungi responsible for these infections, typically clearing symptoms within two to four weeks of daily application.

Yes, Naftifine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL626. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 47641. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.